Table 2.
Number (%) | Proportion treated with RAI at hospital (mean % ± S.D.) |
P Value | ||
---|---|---|---|---|
Number of provider involved in decision making about use of RAI | 0.201 | |||
3 or more | 105 (20%) | 47.88 ± 19.00 | ||
2 | 332 (63%) | 45.86 ± 21.35 | ||
1 | 90 (17%) | 42.48 ± 22.52 | ||
Number of providers administering RAI | <0.001 | |||
3 or more | 240 (46%) | 47.47 ± 19.21 | ||
2 | 143 (27%) | 48.76 ± 19.46 | ||
1 | 102 (20%) | 44.55 ± 25.01 | ||
0 | 36 (7%) | 29.28 ± 22.63 | ||
Access to tumor board | 0.011 | |||
Yes | 395 (71%) | 47.54 ± 20.50 | ||
No | 158 (29%) | 42.55 ± 22.04 | ||
Frequency of tumor board | 0.188 | |||
Weekly | 166 (42%) | 49.42 ± 19.61 | ||
Twice a month | 73 (19%) | 48.15 ± 19.14 | ||
Once a month | 134 (34%) | 44.31 ± 22.57 | ||
Other | 20 (5%) | 45.91 ± 20.22 | ||
Same day visits with other providers | 0.791 | |||
Yes | 110 (20%) | 45.46 ± 19.66 | ||
No | 446 (80%) | 46.06 ± 21.55 | ||
Primary decision maker on whether or not to administer RAI | 0.004 | |||
Surgeon | 87 (16%) | 42.29 ± 21.57 | ||
Endocrinologist | 374 (69%) | 45.42 ± 20.37 | ||
NM/Radiol/Other | 83 (15%) | 52.50 ± 23.05 | ||
Primary decision maker on dose of RAI | 0.894 | |||
Surgeon | 4 (1%) | 41.22 ± 18.63 | ||
Endocrinologist | 232 (45%) | 46.27 ± 20.26 | ||
NM/Radiol/Other | 282 (54%) | 46.14 ± 21.91 | ||
Primarily administers RAI | 0.192 | |||
Surgeon | 0 (0%) | |||
Endocrinologist | 165 (31%) | 44.18 ± 21.72 | ||
NM/Radiol/Other | 361 (69%) | 46.80 ± 21.22 | ||
Surgeon involved in RAI decision making | 0.591 | |||
Yes | 414 (74%) | 45.73 ± 21.20 | ||
No | 143 (26%) | 46.83 ± 21.07 |
RAI = radioactive iodine, NM = nuclear medicine provider